Home » Prescription Drugs 15 » Terbinafine DP Lamisil
IndicationsOnychomycosis (fungal infection of the nail) caused by dermatophyte fungi.Tinea capitis.Fungal infections of the skin for the treatment of tinea corporis tinea cruris tinea pedis and yeast infections of the skin caused by the genus Candida (e.g. Candida albicans) where oral therapy is generally considered appropriate owing to the site severity or extent of the infection.Note: In contrast to topical Terbinafine oral Terbinafine-DP is not effective in pityriasis versicolor.Dosage and AdministrationThe duration of treatment varies according to the indication and the severity of the infection.ChildrenNo data are available in children under two years of age (usually < 12 kg).Children weighing < 20 kg 62.5 mgChildren weighing 20 to 40 kg 125 mgChildren weighing > 40 kg 250 mgAdults250 mg once a day.Skin infectionsRecommended duration of treatment:Tinea pedis (interdigital plantar/moccasin type): 2 to 6 weeks.Tinea corporis cruris: 2 to 4 weeks.Cutaneous candidiasis: 2 to 4 weeks.Complete resolution of the signs and symptoms of infection may not occur until several weeks after mycological cure.Hair and scalp infectionsRecommended duration of treatment:Tinea capitis: 4 weeks.Tinea capitis occurs primarily in children.OnychomycosisFor most patients the duration of successful treatment is 6-12 weeks.Fingernail onychomycosisSix weeks of therapy is sufficient for fingernail infections in most cases.Toenail onychomycosisTwelve weeks of therapy is sufficient for toenail infections in most cases.Some patients with poor nail outgrowth may require longer treatment. The optimal clinical effect is seen some months after mycological cure and cessation of treatment. This is related to the period required for outgrowth of healthy nail.Use of Terbinafine 250 in the elderlyThere is no evidence to suggest that elderly patients require different dosages or experience different side effects than younger patients. When prescribing tablets for patients in this age group the possibility of pre-existing impairment of liver or kidney function should be considered (see Warnings and Precautions).Use of Terbinafine 250 in childrenIn children above 2 years of age oral Terbinafine-DP has been found to be well tolerated.
Buy Terbinafine DP Lamisil and other Prescription Drugs 15 products online
at Medstore.
789 Buy Online at Medstore - Click Here!

About Terbinafine DP Lamisil:
Product Type: Prescription Drugs 15
Terbinafine-DP ( Lamisil Generic Terbinafine )
Terbinafine-DP (Lamisil Generic Terbinafine)
Lamisil Generic Terbinafine
250mg
Lamisil Generic Terbinafine Terbinafine-DP

View more
Prescription Drugs 15
Previous Product Next Product
Direct Pharmacy:
About Medstore Discount Drugs Pharmacy: Frequently Asked Questions Where are you located? We have shipping facilities in the South Pacific, Europe and the Asia. The shipping address depends on the product you have ordered and from which manufacturer or wholesaler it is being supplied from.
News: Micronutrient powder helps prevent malnutrition in children up to two years old, study review shows
In a systematic review published by the Cochrane Collaboration last week, researchers found that the micronutrient powder used in recent years to combat malnutrition, anemia and iron deficiency in children was very helpful in preventing malnutrition in children six to 24 months old, VOA News reports. WHO epidemiologist Luz Maria De Regil "and other researchers combined the results of eight previous studies involving thousands of children," VOA writes, adding, "The studies were done on three continents, in countries as varied as Haiti, Cambodia and Ghana."
"Specifically, the supplement powder reduced anemia by about one-third and iron deficiency by half compared to no supplement or a placebo," VOA notes. "The micronutrient powder seems to be about equally effective as iron supplements, but the authors say that conclusion should be treated 'cautiously,' because of limited data," the news service adds (Chimes, 9/9).
This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.
ZAART H Hyzaar
Zanaflex (Tizanidine)
Zantac Generic Ranitidine
Zantac (Ranitidine)
Zarontin Generic Ethosuximide
Zarontin Syrup Generic Ethosuximide
Zebeta (Bisoprolol)
Zeffix Generic Imaivudine
Zelnorm (Tegaserod)
Zerit (Stavudine)
Zero Nicotine
Zestoretic (Lisinopril + Hydrochlorothiazide)
Zestril (Lisinopril)
Zestril Prinivil
Zetia (Ezetimibe)
ZIDOVIR 300 AZT
ZIDOVIR AZT
Ziprax Suprax
Zipsydon Geodon
Zithromax Generic Azithromycin
Zithromax (Azithromycin)
Zitrotek Zithromax
ZOBID D Voltaren
Zocon Diflucan
Zocor
Zocor Forte Lipex
Zocor (Simcard)
ZOFLUT Generic Fluticasone
Zofran Generic Ondansetron
Zofran (Ondansetron)
Zoladex Generic Goserelin
Zoloft Lustral
Zomig Generic Zolmitriptan
ZONISEP Zonegran
Zoton Prevacid


|